Expression of Ki-67, p53, α-SMA and COX-2 in lichen planus and related lesions: A pilot study
- PMID: 31211042
- PMCID: PMC6562184
- DOI: 10.1016/j.jobcr.2018.02.003
Expression of Ki-67, p53, α-SMA and COX-2 in lichen planus and related lesions: A pilot study
Abstract
Background: Researchers have struggled to understand the natural history of lesions presenting with both lichenoid features and epithelial dysplasia. Thus the present study was designed to differentiate between OLP, OLP with dysplasia, epithelial dysplasia and epithelial dysplasia with lichenoid features based on the expressions of ki-67, p53, COX-2, and α-SMA.
Materials and methods: Formalin-fixed paraffin-embedded archival specimens of OLP, OLP with dysplasia, epithelial dysplasia and epithelial dysplasia with lichenoid features were subjected to immunohistochemical staining with ki-67, p53, COX-2, and α-SMA.
Results: Ki-67 exhibited strong positivity in 100% (6/6) of epithelial dysplasia cases, 71.4% (5/7) of lichenoid dysplasia cases, 57.1% (4/7) of OLP cases and 60% (3/5) of OLP with dysplasia cases. Strong p53 staining was evident in more cases of lichenoid dysplasia [42.8% (3/7)], while moderate staining was more frequent in OLP cases [42.8% (3/7)] and OLP with dysplasia cases [42.8% (3/7)] and mild intensity was more frequent in epithelial dysplasia cases [50% (3/6)] followed by lichenoid dysplasia cases [42.8% (3/7)], OLP cases [28.5 (2/7)] and OLP with dysplasia cases [40% (2/5)]. COX-2 strong positivity was more frequent in cases of epithelial dysplasia cases [57.1% (4/7)] and OLP [50% (3/6)]. Strong α- SMA staining was noted more frequently in lichenoid dysplasia cases [71.4 (5/7)], followed by OLP cases [42.8% (3/7)] and OLP with dysplasia cases [60% (3/5)].
Conclusions: Ki-67, p53, α-SMA and COX-2 expression do not differentiate between OLP, LP with dysplasia and epithelial dysplasia with lichenoid features.
Keywords: Epithelial dysplasia; Immunohistochemistry; Lichenoid reaction; Oral lichen planus.
Figures




Similar articles
-
Expression of survivin and p53 in oral lichen planus, lichenoid reaction and lichenoid dysplasia: An immunohistochemical study.J Oral Maxillofac Pathol. 2017 Sep-Dec;21(3):456-457. doi: 10.4103/jomfp.JOMFP_39_15. J Oral Maxillofac Pathol. 2017. PMID: 29391729 Free PMC article.
-
Lichenoid dysplasia revisited - evidence from a review of Indian archives.J Oral Pathol Med. 2015 Aug;44(7):507-14. doi: 10.1111/jop.12258. Epub 2014 Sep 15. J Oral Pathol Med. 2015. PMID: 25224597
-
Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67.Oral Oncol. 2006 May;42(5):475-80. doi: 10.1016/j.oraloncology.2005.09.012. Epub 2005 Dec 20. Oral Oncol. 2006. PMID: 16364678
-
Controversies regarding oral lichen planus and lichenoid-dysplastic lesions.Can J Dent Hyg. 2024 Jun 1;58(2):98-105. eCollection 2024 Jun. Can J Dent Hyg. 2024. PMID: 38974821 Free PMC article. Review.
-
Oral lichen planus and epithelial dysplasia with lichenoid features: a review and discussion with special reference to diagnosis.J Investig Clin Dent. 2017 Aug;8(3). doi: 10.1111/jicd.12233. Epub 2016 Jul 21. J Investig Clin Dent. 2017. PMID: 27443699 Review.
Cited by
-
Implications of p53 protein upregulation in oral lichen planus: a systematic review and meta-analysis.Med Oral Patol Oral Cir Bucal. 2024 Nov 1;29(6):e832-e842. doi: 10.4317/medoral.26808. Med Oral Patol Oral Cir Bucal. 2024. PMID: 39396145 Free PMC article.
-
Significance of immunohistochemistry biomarkers in prediction of malignant transformation of oral lichen planus: A systematic review.Med Oral Patol Oral Cir Bucal. 2022 Sep 1;27(5):e480-e488. doi: 10.4317/medoral.25491. Med Oral Patol Oral Cir Bucal. 2022. PMID: 35975803 Free PMC article.
-
The natural history of oral mucosal lesions with both lichenoid and epithelial dysplastic features: a systematic review.Transl Cancer Res. 2020 Apr;9(4):3076-3083. doi: 10.21037/tcr.2020.01.51. Transl Cancer Res. 2020. PMID: 35117670 Free PMC article.
-
Comparison of p53, HSP90, E-cadherin and HPV in oral lichen planus and oral squamous cell carcinoma.Acta Otorhinolaryngol Ital. 2021 Dec;41(6):514-522. doi: 10.14639/0392-100X-N1450. Acta Otorhinolaryngol Ital. 2021. PMID: 34928263 Free PMC article.
-
Oral Lichenoid lesions induced by programmed cell death protein 1 and cytotoxic T-lymphocyte-associated protein 4 bispecific antibody: a case report.BMC Oral Health. 2024 Oct 18;24(1):1240. doi: 10.1186/s12903-024-05036-5. BMC Oral Health. 2024. PMID: 39425127 Free PMC article.
References
-
- Krutchkoff D.J., Eisenberg E. Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol. 1985;60(3):308–315. - PubMed
-
- Patil S., Rao R.S., Sanketh D.S., Warnakulasuriya S. Lichenoid dysplasia revisited-evidence from a review of Indian archives. J Oral Pathol Med. 2014;(September) [Epub ahead of print] - PubMed
-
- Fitzpatrick S.G., Honda K.S., Sattar A., Hirsch S.A. Histologic lichenoid features in oral dysplasia and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(4):511–520. - PubMed
-
- Shibata M.1, Kodani I., Osaki M. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol. 2005;41(3):304–312. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous